BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

146 related articles for article (PubMed ID: 16360341)

  • 1. A partial down-regulation of WASP is sufficient to inhibit podosome formation in dendritic cells.
    Olivier A; Jeanson-Leh L; Bouma G; Compagno D; Blondeau J; Seye K; Charrier S; Burns S; Thrasher AJ; Danos O; Vainchenker W; Galy A
    Mol Ther; 2006 Apr; 13(4):729-37. PubMed ID: 16360341
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A lentiviral vector encoding the human Wiskott-Aldrich syndrome protein corrects immune and cytoskeletal defects in WASP knockout mice.
    Charrier S; Stockholm D; Seye K; Opolon P; Taveau M; Gross DA; Bucher-Laurent S; Delenda C; Vainchenker W; Danos O; Galy A
    Gene Ther; 2005 Apr; 12(7):597-606. PubMed ID: 15616597
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Wiskott-Aldrich syndrome protein and the cytoskeletal dynamics of dendritic cells.
    Calle Y; Chou HC; Thrasher AJ; Jones GE
    J Pathol; 2004 Nov; 204(4):460-9. PubMed ID: 15495215
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Maturation of DC is associated with changes in motile characteristics and adherence.
    Burns S; Hardy SJ; Buddle J; Yong KL; Jones GE; Thrasher AJ
    Cell Motil Cytoskeleton; 2004 Feb; 57(2):118-32. PubMed ID: 14691951
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Retroviral WASP gene transfer into human hematopoietic stem cells reconstitutes the actin cytoskeleton in myeloid progeny cells differentiated in vitro.
    Dewey RA; Avedillo Díez I; Ballmaier M; Filipovich A; Greil J; Güngör T; Happel C; Maschan A; Noyan F; Pannicke U; Schwarz K; Snapper S; Welte K; Klein C
    Exp Hematol; 2006 Sep; 34(9):1161-9. PubMed ID: 16939809
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The Wiskott-Aldrich syndrome.
    Ochs HD; Thrasher AJ
    J Allergy Clin Immunol; 2006 Apr; 117(4):725-38; quiz 739. PubMed ID: 16630926
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Development of hematopoietic stem cell gene therapy for Wiskott-Aldrich syndrome.
    Boztug K; Dewey RA; Klein C
    Curr Opin Mol Ther; 2006 Oct; 8(5):390-5. PubMed ID: 17078381
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Improved lentiviral vectors for Wiskott-Aldrich syndrome gene therapy mimic endogenous expression profiles throughout haematopoiesis.
    Frecha C; Toscano MG; Costa C; Saez-Lara MJ; Cosset FL; Verhoeyen E; Martin F
    Gene Ther; 2008 Jun; 15(12):930-41. PubMed ID: 18323794
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Retrovirus-mediated WASP gene transfer corrects defective actin polymerization in B cell lines from Wiskott-Aldrich syndrome patients carrying 'null' mutations.
    Candotti F; Facchetti F; Blanzuoli L; Stewart DM; Nelson DL; Blaese RM
    Gene Ther; 1999 Jun; 6(6):1170-4. PubMed ID: 10455421
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Expression of human Wiskott-Aldrich syndrome protein in patients' cells leads to partial correction of a phenotypic abnormality of cell surface glycoproteins.
    Huang MM; Tsuboi S; Wong A; Yu XJ; Oh-Eda M; Derry JM; Francke U; Fukuda M; Weinberg KI; Kohn DB
    Gene Ther; 2000 Feb; 7(4):314-20. PubMed ID: 10694812
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Lentiviral vectors transcriptionally targeted to hematopoietic cells by WASP gene proximal promoter sequences.
    Martín F; Toscano MG; Blundell M; Frecha C; Srivastava GK; Santamaría M; Thrasher AJ; Molina IJ
    Gene Ther; 2005 Apr; 12(8):715-23. PubMed ID: 15750617
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Wiskott-Aldrich syndrome.
    Notarangelo LD; Miao CH; Ochs HD
    Curr Opin Hematol; 2008 Jan; 15(1):30-6. PubMed ID: 18043243
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Essential role of neural Wiskott-Aldrich syndrome protein in podosome formation and degradation of extracellular matrix in src-transformed fibroblasts.
    Mizutani K; Miki H; He H; Maruta H; Takenawa T
    Cancer Res; 2002 Feb; 62(3):669-74. PubMed ID: 11830518
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Hematopoietic-specific lentiviral vectors circumvent cellular toxicity due to ectopic expression of Wiskott-Aldrich syndrome protein.
    Toscano MG; Frecha C; Benabdellah K; Cobo M; Blundell M; Thrasher AJ; García-Olivares E; Molina IJ; Martin F
    Hum Gene Ther; 2008 Feb; 19(2):179-97. PubMed ID: 18240968
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Hematopoietic lineage cell-specific protein 1 functions in concert with the Wiskott-Aldrich syndrome protein to promote podosome array organization and chemotaxis in dendritic cells.
    Dehring DA; Clarke F; Ricart BG; Huang Y; Gomez TS; Williamson EK; Hammer DA; Billadeau DD; Argon Y; Burkhardt JK
    J Immunol; 2011 Apr; 186(8):4805-18. PubMed ID: 21398607
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Novel membrane cell projection defects in Wiskott-Aldrich syndrome B cells.
    Andreu N; Aran JM; Fillat C
    Int J Mol Med; 2007 Oct; 20(4):445-50. PubMed ID: 17786274
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Characterization of TccP-mediated N-WASP activation during enterohaemorrhagic Escherichia coli infection.
    Garmendia J; Carlier MF; Egile C; Didry D; Frankel G
    Cell Microbiol; 2006 Sep; 8(9):1444-55. PubMed ID: 16922863
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Expression of WASP and Scar1/WAVE1 actin-associated proteins is differentially modulated during differentiation of HL-60 cells.
    Launay S; Brown G; Machesky LM
    Cell Motil Cytoskeleton; 2003 Apr; 54(4):274-85. PubMed ID: 12601690
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Toll-like receptor 7 and MyD88 knockdown by lentivirus-mediated RNA interference to porcine dendritic cell subsets.
    Alves MP; Neuhaus V; Guzylack-Piriou L; Ruggli N; McCullough KC; Summerfield A
    Gene Ther; 2007 May; 14(10):836-44. PubMed ID: 17330086
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Development of novel efficient SIN vectors with improved safety features for Wiskott-Aldrich syndrome stem cell based gene therapy.
    Avedillo Díez I; Zychlinski D; Coci EG; Galla M; Modlich U; Dewey RA; Schwarzer A; Maetzig T; Mpofu N; Jaeckel E; Boztug K; Baum C; Klein C; Schambach A
    Mol Pharm; 2011 Oct; 8(5):1525-37. PubMed ID: 21851067
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.